Squar Milner Financial Services’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Squar Milner Financial Services’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-93	Closed	-$10K	–	826
2019 Q1	$10K	Hold	93	–	–	0.01%	518
2018 Q4	$9K	Hold	93	–	–	0.01%	478
2018 Q3	$10K	Hold	93	–	–	0.01%	487
2018 Q2	$9K	Buy	+93	New	+$9.02K	0.01%	603

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Squar Milner Financial Services's LKFT Position: Q2 2019 in Review

Squar Milner Financial Services sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2019, closing a stake of 93 shares — an estimated $10K sold.

Squar Milner Financial Services first reported a position in LKFT in Q2 2018 and held it in 4 quarters. The position peaked at $10K in Q1 2019. 102 funds tracked by Wall St. Rank hold LKFT as of Q2 2019.

Squar Milner Financial Services reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Squar Milner Financial Services sold 93 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2019, an estimated $10K.
Squar Milner Financial Services first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2018 and held it in 4 quarters.
Squar Milner Financial Services's Lakefront Biotherapeutics American Depositary Shares position peaked at $10K in Q1 2019.
102 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2019.

Based on Squar Milner Financial Services's 13F filing for Q2 2019, filed 25 Jul 2019.